Both insulin sensitivity and insulin clearance in children and young adults with TYPE I (insulin-dependent) diabetes vary with growth hormone concentrations and with age

Diabetologia

Volumn 43, Issue 1, 2000, Pages 61-68

  Acerini, C L ^a   Cheetham, T D ^b   Edge, J A ^b   Dunger, D B ^b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b NONE

Author keywords

Age; Body mass index; Children and adolescents; Growth hormone; Insulin clearance; Insulin sensitivity; Type I diabetes

Indexed keywords

C PEPTIDE; FATTY ACID; GROWTH HORMONE; HEMOGLOBIN A1C; INSULIN; ISOPHANE INSULIN;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; CHILD; CLINICAL ARTICLE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNORADIOMETRIC ASSAY; INSULIN CLEARANCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SENSITIVITY; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

EID: 0034014590     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050008     Document Type: Article

References (61)

1. 1. Amiel SA, Sherwin RS, Simonson DC, Lauritano AA, Tamborlane WV (1986) Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes. N Engl J Med 315: 215-219
2. 2. Bloch CA, Clemons P, Sperling MA (1987) Puberty decreases insulin sensitivity. J Pediatr 110: 481-487
3. 3. Amiel SA, Caprio S, Sherwin RS, Plewe G, Raymond MW Tamborlane WV (1991) Insulin resistance of puberty: a defect restricted to peripheral glucose metabolism. J Clin Endocrinol Metab 72: 277-282
4. 4. Press M, Tamborlane WV, Sherwin RS (1984) Importance of raised growth hormone levels in mediating the metabolic derangements of diabetes. N Engl J Med 310: 810-815
5. 5. Edge JA, Dunger DB, Matthews DR, Gilbert JP, Smith CP (1990) Increased overnight growth hormone concentrations in diabetics compared with normal adolescents. J Clin Endocrinol Metab 71: 1356-1362
6. 123I]-insulin scanning. J Clin Endocrinol Metab 64: 801-808
7. 7. Waldhausl WK, Bratusch-Marrin P, Kruse V, Jensen I, Nowotny P, Vierhapper H (1985) Effect of insulin antibodies on insulin pharmacokinetics and glucose utilization in insulin-dependent diabetic patients. Diabetes 34: 166-173
8. 8. Navalesi R, Pilo A, Ferrannini E (1978) Kinetic analysis of plasma insulin disappearance in nonketotic patients and in normal subjects. J Clin Invest 61: 197-208
9. 9. Reaven GM, Greenfield MS, Mondon CE, Rosenthal M, Wright D, Reaven EP (1982) Does insulin removal rate from plasma decline with age? Diabetes 31: 670-673
10. 10. Fink RI, Revers RR, Kolterman OG, Olefsky JM (1985) The metabolic clearance rate of insulin and the feedback inhibition of insulin secretion are altered with aging. Diabetes 34: 275-280
11. 11. Trischitta V, Brunetti A, Chiavetta A, Benzi L, Papa V, Vigneri R (1989) Defects in insulin-receptor internalization and processing in monocytes of obese subjects and obese NIDDM patients. Diabetes 38: 1579-1584
12. 12. Schade DS, Eaton RP, Peake GT (1978) The regulation of plasma ketone body concentration by counter-regulatory hormones in man. II. Effects of growth hormone in diabetic man. Diabetes 27: 916-923
13. 13. Arslanian S, Ohki Y, Becker DJ, Drash AL (1992) The dawn phenomenon: comparison between normal and insulin-dependent diabetic adolescents. Pediatr Res 31: 203-206
14. 14. Boyle PJ, Avogaro A, Smith L, Shah SD, Cryer PE, Santiago JV (1992) Abscence of the Dawn Phenomenon and abnormal lipolysis in Type I (insulin dependent) diabetic patients with chronic growth hormone deficiency. Diabetologia 35: 372-379
15. 15. Matthews DR, Edge JA, Dunger DB (1990) An unbiased glucose clamp method using a variable insulin infusion: its application in diabetic adolescents. Diabet Med 7: 246-251
16. 16. McGuire EAH, Helderman JH, Tobin JD, Anders R, Berman M (1976) Effects of arterial versus venous sampling on analysis of glucose kinetics in man. Journal of Appl Physiol 41: 565-573
17. 17. Collins ACG, Pickup JC (1985) Sample preparation and radioimmunoassay for circulating free and antibody bound insulin concentrations in insulin treated diabetics: a reevaluation of methods. Diabet Med 2: 456-460
18. 18. Campbell PJ, Bolli GB, Cryer PE, Gerich JE (1985) Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus. Accelerated glucose production and impaired glucose utilization due to nocturnal surges in growth hormone secretion. N Engl J Med 312: 1473-1479
19. 19. Beaufrere B, Beylot M, Metz C et al. (1988) Dawn phenomenon in Type I (insulin-dependent) diabetic adolescents: influence of nocturnal growth hormone secretion. Diabetologia 31: 607-611
20. 20. Aman J, Kroon M, Karlsson I, Jones I, Hagenas L (1996) Reduced growth hormone secretion improves insulin sensitivity in adolescent girls with Type I diabetes. Acta Paediatr 85: 31-37
21. 21. Castillo MJ, Scheen AJ, Letiexhe MR, Lefebvre PJ (1994) How to measure insulin clearance. Diabetes Metab Rev 10: 119-150
22. 22. Perriello G, DeFeo P, Torlone E et al. (1991) The dawn phenomenon in Type I (insulin-dependent) diabetes mellitus: magnitude, frequency, variability, and dependency on glucose counterregulation and insulin sensitivity. Diabetologia 34: 21-28
23. 23. Jackson RA, Blix PM, Matthews JA et al. (1982) Influence of aging on glucose homeostasis. J Clin Endocrinol Metab 55: 840-848
24. 24. Tuominen JA, Ebeling P, Koivisto VA (1997) Exercise increases insulin clearance in healthy man and insulin-dependent diabetes mellitus patients. Clin Physiol 17: 19-30
25. 25. Heine RJ, Bilo HJG, Van der Meer, J Van der Veen EA (1986) Sequential infusions of glucose and insulin at prefixed rates: a simple method for assessing insulin sensitivity and insulin responsivness. Diabetes Res 3: 453-461
26. 26. Edge JA, Matthews DR, Dunger DB (1990) The dawn phenomenon is related to overnight growth hormone release in adolescent diabetics. Clin Endocrinol (Oxf) 33: 729-737
27. 27. Perriello G, DeFeo P, Torlone E et al. (1990) Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in Type I (insulin dependent) diabetes mellitus by decreasing hepatic (and extrahepatic) sensitivity to insulin in the absence of insulin waning. Diabetologia 33: 52-59
28. 28. Cheetham TD, Connors M, Clayton K, Watts A, Dunger DB (1997) The relationship between overnight GH levels and insulin concentrations in adolescents with insulin-dependent diabetes mellitus (IDDM) and the impact of recombinant human insulin-like growth factor I (rhIGF-I). Clin Endocrinol (Oxf) 46: 415-425
29. 29. Rizza RA, Mandarino LJ, Gerich JE (1982) Effects of growth hormone on insulin action in man. Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization. Diabetes 31: 663-669
30. 30. Bratusch-Marrain PR, Smith D, DeFronzo RA (1982) The effect of growth hormone on glucose metabolism and insulin secretion in man. J Clin Endocrinol Metab 55: 973-982
31. 31. Randle PJ, Garland PB, Hales CN, Newsholme EA (1963) The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic distrubances of diabetes mellitus. Lancet i:785-789
32. 32. Bonadonna RC, Zych K, Boni C, Ferrannini E (1989) Time dependence of the interaction between lipid and glucose in humans. Am J Physiol 257:E49-E56
33. 33. Walker M, Fulcher GR, Sum CF, Orskov H, Alberti KGMM (1991) Effecdt of glycemia and nonesterified fatty acids on forearm glucose uptake in normal humans. Am J Physiol 261:E304-E311
34. 34. Cherrington AD, Edgerton D, Sindelar DK (1998) The direct and indirect effects of insulin on hepatic glucose production in vivo. Diabetologia 41: 987-996
35. 35. Piatti PM, Monti LD, Caumo A et al. (1999) Mediation of the hepatic effects of growth hormone by its lipolytic activity. J Clin Endocrinol Metab 84: 1658-1663
36. 36. Okuda Y, Pena J, Chou J, Field JB (1994) Effect of growth hormone on hepatic glucose and insulin metabolism after oral glucose in concious dogs. Am J Physiol 267:E454-E460
37. 37. Monti LD, Brambillla P, Caumo A et al. (1997) Glucose turnover and insulin clearance after growth hormone treatment in girls with Turner's syndrome. Metabolism 46: 1482-1488
38. 38. Widmer A, Keller U, Pasquel M, Berger W (1988) Alterations in insulin clearance and hepatic blood flow during the night do not contribute to the 'Dawn Phenomenon' in Type I diabetes. Hormone Res 29: 197-201
39. 39. DeFeo P, Perriello G, Ventura MM et al. (1986) Studies on overnight insulin requirements and metabolic clearance rat of insulin in normal and diabetic man: relevance to the pathogenesis of the dawn phenomenon. Diabetologia 29: 475-480
40. 40. Brennan JR, Gebhart SSP, Blackard WG (1985) Pump-induced insulin aggregation: a problem with the Biostator. Diabetes 34: 353-359
41. 41. Van Haeften TW, Bolli GB, Dimitriadis GD, Gottesman IS, Horwitz DL, Gerich JE (1986) Effect of insulin antibodies and their kinetic characteristics on plasma free insulin dynamics in patients with diabetes mellitus. Metabolism 35: 649-656
42. 42. Toft I, Bonaa KH, Lindal S, Jenssen T (1998) Insulin kinetics, insulin action, and muscle morphology in lean and slightly overweight persons with impaired glucose tolerance. Metabolism 47: 848-854
43. 43. Ciampelli M, Fulghesu AM, Cucinelli F et al.(1997) Heterogeneity in beta cell activity, hepatic insulin clearance and peripheral insulin sensitivity in women with polycystic ovary syndrome. Hum Reprod 12: 1897-1901
44. 44. Van Haeften TW, Bolli GB, Dimitriadis GD, Gottesman IS, Horwitz DL, Gerich JE (1986) Effect of insulin antibodies and their kinetic characteristics on plasma free insulin dynamics in patients with diabetes mellitus. Metabolism 35: 649-656
45. 45. Campbell PJ, Gerich JE (1990) Impact of obesity on insulin action in volunteers with normal glucose tolerance: Demonstration of a threshold for the adverse effect of obesity. J Clin Endocrinol Metab 70: 1114-1118
46. 46. Macor C, Ruggeri A, Mazzonetto P, Federspil G, Cobelli C, Vettor R (1997) Visceral adipose tissue impairs insulin secretion and insulin sensitivity but not energy expenditure in obesity. Metabolism 46: 123-129
47. 47. Mingrone G, DeGaetano A, Greco AV et al. (1997) Reversibility of insulin resistance in obese diabetic patients: role of plasma lipids. Diabetologia 40: 599-605
48. 48. Phillips DIW, Caddy S, Ilic V et al. (1996) Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in nondiabetic subjects. Metabolism 45: 947-950
49. 49. Svedberg J, Bjorntorp P, Smith U, Lonnroth P (1990) Free-fatty acid inhibition of insulin binding, degradation, and action in isolated rat hepatocytes. Diabetes 39: 570-574
50. 50. Pagano C, Rizzato M, Lombardi AM et al. (1996) Effect of lactate on hepatic insulin clearance in perfused rat liver. Am J Physiol 270:R682-R687
51. 51. Boden G (1997) Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46: 3-10
52. 52. Edge JA, Pal BR, Harris DA, Matthews DR, Phillips PE, Dunger DB (1993) Evidence for a role for insulin and growth hormone in the overnight regulation of 3-hydroxybutyrate in normal and diabetic adolescents. Diabetes Care 16: 1011-1018
53. 53. Rizack MA (1960) Intravascular effect of heparin on plasma nonesterified fatty acid and triglyceride during alimentary lipemia. Proc Soc Exp Biol Med 104: 111-113
54. 54. Miller DS, Sykes DB (1991) Stimulation of protein synthesis by internalised insulin. J Cell Physiol 147: 487-494
55. 55. Seta KA, Roth RA (1997) Overexpression of insulin degradation enzyme: cellular localization and effects on insulin signaling. Biochem Biophys Res Commun 231: 167-171
56. 56. Duckworth WC, Hamel FG, Peavy DE (1988) Hepatic metabolism of insulin. Am J Med 85: 71-76
57. 57. Sato H, Terasaki T, Mizuguchi H, Okumura K, Tsuji A (1991) Receptor-recycling model of clearance and distribution of insulin in the perfused mouse liver. Diabetologia 34: 613-621
58. 58. Letiexhe MR, Scheen AJ, Gerard PJ et al. (1993) Insulin secretion, clearance, and action on glucose metabolism in cirrhotic patients. J Clin Endocrinol Metab 77: 1263-1268
59. 59. Jones CN, Pei D, Staris P, Polonsky KS, Chen YDI, Reaven GM (1997) Alterations in glucose-stimulated insulin secretory dose-response curve and insulin clearance in nondiabetic insulin resistant individuals. J Clin Endocrinol Metab 82: 1834-1838
60. 60. Nijs HGT, Radder JK, Frolich M, Krans HMJ (1990) In vivo relationship between insulin clearance and action in healthy subjects and IDDM patients. Diabetes 39: 333-339
61. 61. Mosthaf L, Busch AK, Juhl LF, Nieslen L, Olsen GS, Ikeda Y, Seedorf K (1998) The insulin receptor is degraded by specific protein kinase C isoforms. Diabetologia 41 [Suppl 1]:532